Rigel Pharmaceuticals Net Profit Margin 2006-2020 | RIGL

Rigel Pharmaceuticals net profit margin from 2006 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Rigel Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.11B $-0.03B -23.15%
2020-03-31 $0.10B $-0.03B -27.45%
2019-12-31 $0.06B $-0.07B -113.56%
2019-09-30 $0.08B $-0.05B -57.32%
2019-06-30 $0.07B $-0.06B -90.91%
2019-03-31 $0.06B $-0.07B -112.07%
2018-06-30 $0.00B $-0.09B -3133.33%
2017-09-30 $0.01B $-0.07B -850.00%
2017-03-31 $0.02B $-0.07B -340.00%
2016-12-31 $0.02B $-0.07B -333.33%
2016-09-30 $0.03B $-0.07B -248.15%
2016-06-30 $0.04B $-0.05B -141.67%
2016-03-31 $0.03B $-0.05B -159.38%
2015-12-31 $0.03B $-0.05B -179.31%
2012-06-30 $0.01B $-0.09B -1314.29%
2012-03-31 $0.01B $-0.09B -1760.00%
2011-09-30 $0.00B $-0.08B -1925.00%
2011-06-30 $0.07B $-0.01B -12.50%
2010-12-31 $0.12B $0.04B 30.65%
2007-12-31 $0.01B $-0.07B -569.23%
2007-06-30 $0.01B $-0.06B -442.86%
2007-03-31 $0.03B $-0.05B -173.08%
2006-12-31 $0.03B $-0.04B -109.09%
2006-09-30 $0.04B $-0.03B -83.33%
2006-06-30 $0.03B $-0.03B -96.97%
2006-03-31 $0.02B $-0.04B -175.00%
2005-12-31 $0.02B $-0.05B -264.71%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.422B $0.059B
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year. The Company's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, as well as in cancer.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.154B 43.89
Takeda Pharmaceutical (TAK) Japan $52.462B 9.14
Astellas Pharma (ALPMY) Japan $26.307B 0.00
Eisai (ESALY) Japan $23.722B 20.05
UCB SA (UCBJF) Belgium $21.561B 0.00
Merck (MKGAF) Germany $19.677B 25.81
Ono Pharmaceutical (OPHLF) Japan $15.938B 28.18
Catalent (CTLT) United States $15.365B 49.95
Grifols, S.A (GRFS) Spain $12.513B 15.29
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.683B 25.17
Neurocrine Biosciences (NBIX) United States $9.002B 34.85
Jazz Pharmaceuticals (JAZZ) Ireland $8.384B 13.87
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.221B 0.00
IPSEN SA ADR (IPSEY) France $7.439B 0.00
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Ionis Pharmaceuticals (IONS) United States $6.592B 41.76
Orion OYJ (ORINY) Finland $6.272B 21.76
Arrowhead Pharmaceuticals (ARWR) United States $5.990B 0.00
United Therapeutics (UTHR) United States $5.423B 12.54
Evotec AG (EVTCY) Germany $4.189B 145.40
FibroGen (FGEN) United States $4.121B 0.00
ChemoCentryx (CCXI) United States $3.788B 0.00
Sage Therapeutics (SAGE) United States $3.681B 0.00
PTC Therapeutics (PTCT) United States $3.519B 0.00
Hypermarcas (HYPMY) Brazil $3.452B 12.70
Nektar Therapeutics (NKTR) United States $3.074B 0.00
Revolution Medicines (RVMD) United States $2.601B 0.00
Pacira BioSciences (PCRX) United States $2.321B 61.02
Taro Pharmaceutical Industries (TARO) Israel $2.284B 11.06
Xencor (XNCR) United States $2.261B 0.00
Cronos Group (CRON) Canada $2.124B 0.00
Corcept Therapeutics (CORT) United States $2.052B 18.89
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.921B 0.00
USANA Health Sciences (USNA) United States $1.765B 15.55
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.624B 15.49
Ironwood Pharmaceuticals (IRWD) United States $1.518B 10.54
Heron Therapeutics (HRTX) United States $1.494B 0.00
Endo (ENDP) Ireland $1.331B 1.97
Trillium Therapeutics (TRIL) Canada $1.307B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.217B 0.00
Zogenix (ZGNX) United States $1.164B 0.00
Karyopharm Therapeutics (KPTI) United States $1.134B 0.00
Translate Bio (TBIO) United States $1.074B 0.00
Indivior (INVVY) United States $1.055B 13.07
CLINIGEN GP (CLIGF) United Kingdom $1.028B 0.00
ImmunoGen (IMGN) United States $0.960B 0.00
Esperion Therapeutics (ESPR) United States $0.886B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.877B 545.88
Tilray (TLRY) Canada $0.869B 0.00
Vectura Group (VEGPF) United Kingdom $0.795B 0.00
Ocular Therapeutix (OCUL) United States $0.736B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.678B 0.00
Collegium Pharmaceutical (COLL) United States $0.659B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.655B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.647B 32.28
Radius Health (RDUS) United States $0.630B 0.00
Flexion Therapeutics (FLXN) United States $0.599B 0.00
VAXART, INC (VXRT) United States $0.597B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.526B 0.00
Siga Technologies (SIGA) United States $0.519B 55.33
Molecular Templates (MTEM) United States $0.489B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.480B 0.00
Ardelyx (ARDX) United States $0.472B 0.00
Akebia Therapeutics (AKBA) United States $0.470B 0.00
Aerie Pharmaceuticals (AERI) United States $0.450B 0.00
Organogenesis Holdings (ORGO) United States $0.419B 0.00
TherapeuticsMD (TXMD) United States $0.414B 0.00
Altimmune (ALT) United States $0.384B 0.00
Harpoon Therapeutics (HARP) United States $0.378B 0.00
DURECT (DRRX) United States $0.377B 0.00
Concert Pharmaceuticals (CNCE) United States $0.359B 0.00
Redhill Biopharma (RDHL) Israel $0.358B 0.00
Profound Medical (PROF) Canada $0.353B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.329B 8.15
Jounce Therapeutics (JNCE) United States $0.325B 15.40
Menlo Therapeutics (VYNE) United States $0.322B 0.00
MEI Pharma (MEIP) United States $0.314B 0.00
Innate Pharma SA (IPHYF) France $0.311B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.304B 0.00
Lannett Co Inc (LCI) United States $0.283B 6.58
KalVista Pharmaceuticals (KALV) United States $0.282B 0.00
Rafael Holdings (RFL) United States $0.266B 0.00
Calithera Biosciences (CALA) United States $0.258B 0.00
Xeris Pharmaceuticals (XERS) United States $0.255B 0.00
Aduro Biotech (KDNY) United States $0.250B 0.00
CTI BioPharma (CTIC) United States $0.246B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.242B 0.00
IMV INC (IMV) Canada $0.231B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.222B 0.00
Nature's Sunshine Products (NATR) United States $0.213B 21.02
CASI Pharmaceuticals (CASI) United States $0.198B 0.00
Nivalis Therapeutics (ALPN) United States $0.189B 0.00
Aclaris Therapeutics (ACRS) United States $0.182B 0.00
Aquestive Therapeutics (AQST) United States $0.179B 0.00
Otonomy (OTIC) United States $0.177B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.177B 0.00
Taiwan Liposome (TLC) Taiwan $0.176B 0.00
Heat Biologics (HTBX) United States $0.175B 0.00
OptiNose (OPTN) United States $0.174B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.171B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.167B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.112B 0.00
MediWound (MDWD) Israel $0.097B 0.00
ProPhase Labs (PRPH) United States $0.097B 0.00
Lipocine (LPCN) United States $0.090B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.085B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.078B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.076B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.075B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.073B 0.00
Novan (NOVN) United States $0.072B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.071B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.070B 0.00
ElectroCore (ECOR) United States $0.070B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
Addex Therapeutics (ADXN) Switzerland $0.068B 0.00
Biomerica (BMRA) United States $0.067B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
AgeX Therapeutics (AGE) United States $0.060B 0.00
Onconova Therapeutics (ONTX) United States $0.051B 0.00
Natural Alternatives (NAII) United States $0.050B 0.00
SCYNEXIS (SCYX) United States $0.050B 0.00
India Globalization Capital (IGC) United States $0.049B 0.00
Recro Pharma (REPH) United States $0.047B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.045B 27.27
Forward Pharma (FWP) Denmark $0.044B 0.00
Neos Therapeutics (NEOS) United States $0.042B 0.00
PolarityTE (PTE) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.93
GTx (ONCT) United States $0.033B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.031B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.031B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.030B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
IsoRay (ISR) United States $0.026B 0.00
Midatech Pharma (MTP) United Kingdom $0.026B 0.00
Vical (BBI) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Regulus Therapeutics (RGLS) United States $0.019B 0.00
Sundial Growers (SNDL) Canada $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Cyanotech (CYAN) United States $0.017B 26.27
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.015B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.013B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
China SXT Pharmaceuticals (SXTC) China $0.011B 0.00
Shineco (TYHT) China $0.009B 0.00
JanOne (JAN) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00